Manulife closes long-term care deal: what it means for Manulife stock

Published on 10/06/2026 at 16:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Manulife transferred 80% of a CAD 3.20 billion block on October 1, 2026. For Manulife stock this means 24% lower long-term care sensitivity.

MFC, CA56501R1064, Illustration mit AI erstellt.

Manulife closed a long-term care reinsurance transaction covering 80% of a CAD 3.20 billion reserve block on October 1, 2026, transferring biometric risk to Munich Re Life US, according to Yahoo Finance. The deal is the latest step in Manulife's effort to reduce exposure to long-term care claims, giving the headline event a measurable risk-management angle for Manulife stock.

What the reinsurance deal means

The transaction covers a policy block with reserves measured under IFRS 17 at June 30, 2026. The 80% quota share means Munich Re Life US assumes the specified biometric risk while Manulife retains policy administration, according to StockTitan.

Manulife said the transaction brought its cumulative reduction in long-term care morbidity sensitivity to 24% after three transactions. The company expects the capital effect to be largely neutral, while the first-year impact on core earnings is about CAD 30 million, with the effect declining as the block runs off, according to Reinsurance News.

Second-quarter figures add context

Manulife's second-quarter 2026 results provide the operating backdrop. Core earnings rose 12% year over year, core earnings per share increased 16%, and annualized premium equivalent sales grew 21%, according to Benzinga.

The same quarter produced a core return on equity of 16.3%, up 130 basis points from the prior-year quarter, while the Life Insurance Capital Adequacy Test ratio stood at 136%. Asia core earnings rose 21% year over year, but Canada core earnings fell 10%, showing why risk transfer and geographic diversification remain central to the investment case.

Market value and next date

On October 6, 2026 at 10:47 a.m. ET, Manulife stock was trading at USD 43.41 on the NYSE, up 1.09 percent from the USD 42.94 prior close. The same quote showed a USD 31.41 to USD 45.33 52-week range and a market capitalization of USD 72.4 billion.

Manulife's next earnings date is November 4, 2026, according to Simply Wall St. That report will test whether the second-quarter growth rates and the company's long-term care risk actions are translating into sustained earnings quality.